October 15, 2020
6:20 PM – 8:00 PM (PST)
Clinicians providing infusion therapy to people with multiple sclerosis (MS) need access to the most current clinical information and real-world data in this area. This virtual program will review their mechanisms of action, efficacy, and safety of currently available MS infusion therapies. It will provide comprehensive guidance on the important clinical steps to be undertaken before, during, and after administration of infusion therapies. Two real-world patient case discussions will offer attendees the opportunity to consider best practices, share potential approaches and solutions to the case challenges, as well as have their questions regarding infusion therapies answered.
6:20 PM – 6:30 PM Audio / Video Test and Preassessment
6:30 PM – 7:10 PM Presentation
7:10 PM – 7:55 PM Case Discussion and Clinical Exchange
7:55 PM – 8:00 PM Postassessment/Evaluation
Carrie M. Hersh, DO, MSc
Physicians, nursing professionals, pharmacists, and other members of the healthcare team who care for patients with MS.
Upon completion of this activity, learners should be better able to:
- ANALYZE the mechanisms of action and therapeutic targets for available infusible DMTs in order to inform the therapeutic decision-making process
- INDIVIDUALIZE infusible therapies based on safety and efficacy data, current guidelines, and patient preferences
- MONITOR individuals for tolerability, response to therapy, and infusion-related reactions
- DISCUSS infusion procedures, potential adverse effects, and post-infusion care recommendations with people receiving infusible DMTs and their families
This educational activity is jointly provided by The Consortium of Multiple Sclerosis Centers, International Organization of Multiple Sclerosis Nurses, and Spire Learning.
Commercial Support Acknowledgement
This activity is supported by an educational grant from Genentech, Inc. and Sanofi Genzyme.
Disclosure of Financial Relationships
It is the policy of CMSC, IOMSN and Spire Learning to ensure balance, independence, objectivity, and scientific rigor in all educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed any relevant financial relationships they or their spouse/life partner have within the previous 12 months with manufacturers of any commercial products/devices and/or providers of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. All presentations were reviewed by independent clinicians with no relevant financial relationships for the purpose of resolution of any identified conflict of interest and a determination of evidence-base and fair balance.
The following expert faculty educator will present and lead the case-based discussion at these meetings.
Carrie M. Hersh, DO, MSc
Lou Ruvo Center for Brain Health
Las Vegas, NV
ACCREDITATION AND CREDIT DESIGNATION
In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Spire Learning. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement:
The CMSC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit Designation Statement:
The CMSC designates this live activity for a maximum of 1.5 contact hours of continuing nursing education (including pharmacotherapeutic contact hours).
Pharmacist Credit Designation Statement
The Consortium of Multiple Sclerosis Centers (CMSC) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education and will award 1.5 contact hours (.15 CEUs) to pharmacists who (1) participate in the activity, and (2) complete the evaluation form. The Universal Activity Number (UAN) for this activity is JA4008165-9999-20-001-L01-P. This is a knowledge-based activity.
Upon successful completion of the activity, your CE credits will be submitted electronically to the NABP CPE Monitor service. For information about CPE Monitor, visit https://nabp.pharmacy/cpe-monitor-service/.
5 Sylvan Way
Parsippany, NJ 07054
Per regulatory guidelines, the educational grant used to support this activity may only be used for medical professionals attending the activity. Our grant funding does not allow for participation by non-healthcare providers and/or guests.
Please preregister to attend this educational activity. Participants will be accommodated on a first-come, first-served basis.
JOINTLY PROVIDED BY